HealthEquity (HQY) Shares Sold by Wells Fargo & Company MN

Wells Fargo & Company MN trimmed its stake in HealthEquity (NASDAQ:HQY) by 10.3% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 978,057 shares of the company’s stock after selling 112,616 shares during the period. Wells Fargo & Company MN owned about 1.60% of HealthEquity worth $59,211,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Global X Management Co. LLC lifted its holdings in shares of HealthEquity by 180.6% during the 4th quarter. Global X Management Co. LLC now owns 36,601 shares of the company’s stock worth $1,708,000 after acquiring an additional 23,556 shares during the period. Signition LP bought a new position in shares of HealthEquity during the 4th quarter worth about $348,000. California Public Employees Retirement System lifted its holdings in shares of HealthEquity by 7.5% during the 4th quarter. California Public Employees Retirement System now owns 103,028 shares of the company’s stock worth $4,807,000 after acquiring an additional 7,169 shares during the period. Rock Springs Capital Management LP lifted its holdings in HealthEquity by 18.2% during the 4th quarter. Rock Springs Capital Management LP now owns 195,000 shares of the company’s stock valued at $9,099,000 after purchasing an additional 30,000 shares during the last quarter. Finally, AXA lifted its holdings in HealthEquity by 9.6% during the 4th quarter. AXA now owns 52,866 shares of the company’s stock valued at $2,467,000 after purchasing an additional 4,619 shares during the last quarter. Institutional investors own 98.54% of the company’s stock.

In other news, insider Stephen Neeleman sold 240,654 shares of HealthEquity stock in a transaction that occurred on Thursday, May 10th. The shares were sold at an average price of $69.95, for a total transaction of $16,833,747.30. Following the completion of the sale, the insider now owns 654 shares in the company, valued at approximately $45,747.30. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CMO Gary D. Robinson sold 500 shares of HealthEquity stock in a transaction that occurred on Thursday, April 12th. The stock was sold at an average price of $64.00, for a total transaction of $32,000.00. Following the sale, the chief marketing officer now owns 3,490 shares of the company’s stock, valued at approximately $223,360. The disclosure for this sale can be found here. Insiders sold a total of 551,342 shares of company stock valued at $37,645,235 in the last 90 days. Corporate insiders own 4.00% of the company’s stock.

HQY opened at $76.94 on Monday. The stock has a market capitalization of $4.69 billion, a price-to-earnings ratio of 142.48, a P/E/G ratio of 3.08 and a beta of 1.39. HealthEquity has a 1-year low of $40.21 and a 1-year high of $77.19.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings data on Monday, March 19th. The company reported $0.06 earnings per share for the quarter, meeting the consensus estimate of $0.06. The firm had revenue of $60.44 million during the quarter, compared to analysts’ expectations of $58.46 million. HealthEquity had a net margin of 20.64% and a return on equity of 13.47%. equities research analysts forecast that HealthEquity will post 0.77 earnings per share for the current fiscal year.

Several equities analysts recently issued reports on the stock. Citigroup lifted their price target on shares of HealthEquity from $58.00 to $68.00 and gave the company an “outperform” rating in a report on Tuesday, March 20th. Cantor Fitzgerald lifted their price target on shares of HealthEquity from $56.00 to $60.00 and gave the company an “overweight” rating in a report on Wednesday, February 7th. Robert W. Baird lifted their price target on shares of HealthEquity from $48.00 to $49.00 and gave the company a “neutral” rating in a report on Wednesday, February 7th. Zacks Investment Research downgraded shares of HealthEquity from a “buy” rating to a “hold” rating in a report on Saturday, May 12th. Finally, SunTrust Banks lifted their price target on shares of HealthEquity to $70.00 and gave the company a “buy” rating in a report on Tuesday, March 20th. Two investment analysts have rated the stock with a hold rating, nine have issued a buy rating and two have given a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average target price of $69.64.

HealthEquity Company Profile

HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply